Lv1
74 积分 2024-09-08 加入
Biology, vulnerabilities and clinical applications of circulating tumour cells
2天前
已完结
Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
2天前
已完结
Data from Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma
2天前
已关闭
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance
2天前
已完结
Contribution of platelets to tumour metastasis
3天前
已完结
Therapeutic developments in pancreatic cancer
28天前
已完结
Therapeutic targeting of tumour myeloid cells
28天前
已完结
Myeloid-derived suppressor cells in cancer and cancer therapy
1个月前
已完结
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
1个月前
已完结
Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer
1个月前
已完结
皖公网安备34019202002308
